Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair

Integrins have been suggested as possible targets in anticancer therapy. Here we show that knockdown of integrins αVβ3, αVβ5, α3β1 and α4β1 and pharmacological inhibition using a cyclo-RGD integrin αVβ3/αVβ5 antagonist sensitized multiple high-grade glioma cell lines to temozolomide (TMZ)-induced cy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Christmann, Markus, Diesler, Kathrin, Majhen, Dragomira, Steigerwald, Christian, Berte, Nancy, Freund, Halima, Stojanović, Nikolina, Kaina, Bernd, Osmak, Maja, Ambriović-Ristov, Andreja, Tomicic, Maja T.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5438606/
https://ncbi.nlm.nih.gov/pubmed/27487141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10897
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares